Ascendis Pharma A/S Ordinary Share (ASND) Stock Price, Quote & AI Analysis
Live ASND stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Ascendis Pharma A/S Ordinary Share.
TradeVae provides AI-driven analysis and real-time market intelligence for Ascendis Pharma A/S Ordinary Share (ASND), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Ascendis Pharma A/S Ordinary Share's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Ascendis Pharma A/S Ordinary Share Overview
Company information
Company Overview
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Ascendis Pharma A/S Ordinary Share Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...